Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details)

v3.23.2
Stockholders Equity (Details) - USD ($)
 6 Months Ended
May 04, 2023
Mar. 01, 2023
Feb. 27, 2023
Feb. 22, 2023
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2023
Jun. 30, 2022
Apr. 24, 2023
Dec. 31, 2022
Nov. 30, 2017
Stockholders Equity (Details) [Line Items]                      
Share issued (in Shares)       15,997,448         24,632,243    
Shares issued price per share (in Dollars per share)       $ 0.245 $ 2.57            
Gross proceeds       $ 7,484,000              
Exercise price per share (in Dollars per share)     $ 0.001                
Net proceeds     $ 1,293,000                
Issuance cost     $ 176,000                
Common stock shares issued (in Shares) 12,797,957                    
Exercisable price per share (in Dollars per share) $ 1.000                    
Offering price amount           $ 50,000,000          
Common stock under agreement (in Shares)             45,979,730 27,171   29,982,282  
Average price per share (in Dollars per share)               $ 1.36      
Net proceeds from sales agreement               $ 37,000      
Aggregate commission amount             $ 1        
Amount receivable         $ 5,000,000            
Equity method of investment         3,000,000            
Additional received amount         2,000,000            
Aggregate amount         $ 2,000,000            
Preferred stock, shares authorized (in Shares)             1,000,000     1,000,000  
Preferred stock, par value (in Dollars per share)             $ 0.0001     $ 0.0001  
Granted option shares (in Shares)   1,543,000                  
Exercise price (in Dollars per share)             $ 0.001        
Vesting period term   4 years                  
Fair value of grant date             $ 487,000        
Pre funded warrants [Member]                      
Stockholders Equity (Details) [Line Items]                      
Pre-funded warrants (in Shares)       14,610,714              
Shares issued price per share (in Dollars per share)       $ 0.244              
Net proceeds $ 5,859,000                    
Issuance cost $ 157,000                    
Warrant [Member]                      
Stockholders Equity (Details) [Line Items]                      
Share issued (in Shares)     3,199,491                
Pre-funded warrants (in Shares) 11,834,286   2,776,428                
Gross proceeds     $ 1,469,000                
Exercise price (in Dollars per share)                    
Shares of issued warrants (in Shares)             2,974        
Preferred Stock [Member]                      
Stockholders Equity (Details) [Line Items]                      
Preferred stock, shares authorized (in Shares)             1,000,000        
Second Tranche [Member]                      
Stockholders Equity (Details) [Line Items]                      
Shares issued price per share (in Dollars per share)         $ 2.57            
Founder [Member]                      
Stockholders Equity (Details) [Line Items]                      
Shares of issued warrants (in Shares)                     2,974
Pre funded warrants [Member] | Minimum [Member]                      
Stockholders Equity (Details) [Line Items]                      
Percentage of ownership             9.90%        
Pre funded warrants [Member] | Maximum [Member]                      
Stockholders Equity (Details) [Line Items]                      
Percentage of ownership             9.99%        
Stock Options [Member]                      
Stockholders Equity (Details) [Line Items]                      
Exercise price (in Dollars per share)   $ 0.4                  
Equity Method Investment [Member]                      
Stockholders Equity (Details) [Line Items]                      
Equity method of investment         $ 2,000,000